State of Alaska Department of Revenue lessened its stake in shares of Healthequity Inc (NASDAQ:HQY) by 7.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,652 shares of the company’s stock after selling 903 shares during the quarter. State of Alaska Department of Revenue’s holdings in Healthequity were worth $863,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of the business. Lenox Wealth Advisors LLC bought a new stake in shares of Healthequity during the 4th quarter valued at about $28,000. Griffin Asset Management Inc. bought a new stake in shares of Healthequity during the 2nd quarter valued at about $29,000. CSat Investment Advisory L.P. bought a new stake in shares of Healthequity during the 2nd quarter valued at about $67,000. Tower Research Capital LLC TRC boosted its position in shares of Healthequity by 145.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,044 shares of the company’s stock valued at $68,000 after acquiring an additional 619 shares during the last quarter. Finally, Quadrant Capital Group LLC boosted its position in shares of Healthequity by 14.0% during the 3rd quarter. Quadrant Capital Group LLC now owns 1,562 shares of the company’s stock valued at $88,000 after acquiring an additional 192 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.
NASDAQ:HQY opened at $73.02 on Friday. The business has a 50 day moving average of $71.19 and a 200 day moving average of $65.20. The company has a market capitalization of $5.17 billion, a price-to-earnings ratio of 55.68, a PEG ratio of 2.58 and a beta of 1.51. Healthequity Inc has a 1-year low of $50.87 and a 1-year high of $85.07. The company has a debt-to-equity ratio of 1.25, a current ratio of 1.91 and a quick ratio of 1.91.
Healthequity (NASDAQ:HQY) last released its earnings results on Tuesday, December 3rd. The company reported $0.47 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.14 by $0.33. The company had revenue of $157.12 million during the quarter, compared to the consensus estimate of $152.38 million. Healthequity had a return on equity of 11.31% and a net margin of 13.03%. Healthequity’s quarterly revenue was up 122.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.25 EPS. As a group, sell-side analysts anticipate that Healthequity Inc will post 1.13 EPS for the current year.
A number of analysts have recently issued reports on the company. Wells Fargo & Co lifted their price target on Healthequity from $76.00 to $80.00 and gave the company an “overweight” rating in a research report on Wednesday, January 8th. Goldman Sachs Group assumed coverage on Healthequity in a research report on Monday, October 7th. They set a “neutral” rating and a $56.00 price target for the company. Barrington Research reiterated a “buy” rating and set a $75.00 price target on shares of Healthequity in a research report on Monday, December 2nd. KeyCorp reiterated a “buy” rating and set a $77.00 price target (up previously from $70.00) on shares of Healthequity in a research report on Wednesday, December 4th. Finally, Zacks Investment Research upgraded Healthequity from a “sell” rating to a “buy” rating and set a $62.00 price target for the company in a research report on Tuesday, November 5th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $76.31.
In related news, CFO Darcy G. Mott sold 4,000 shares of the business’s stock in a transaction that occurred on Friday, December 20th. The stock was sold at an average price of $76.53, for a total value of $306,120.00. Following the completion of the sale, the chief financial officer now owns 34,000 shares in the company, valued at approximately $2,602,020. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders sold a total of 12,000 shares of company stock valued at $775,280 in the last 90 days. 3.70% of the stock is currently owned by corporate insiders.
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also: Is a Roth IRA right for you?
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.